TFB Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
TFB Advisors's PFE Position: Q1 2026 in Review
TFB Advisors sold out of Pfizer (PFE) in Q1 2026, closing a stake of 8,307 shares — an estimated $207K sold.
TFB Advisors first reported a position in PFE in Q4 2022 and held it in 11 quarters. The position peaked at $1.04M in Q2 2023. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- TFB Advisors reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- TFB Advisors sold 8,307 Pfizer shares in Q1 2026, an estimated $207K.
- TFB Advisors first reported a position in Pfizer in Q4 2022 and held it in 11 quarters.
- TFB Advisors's Pfizer position peaked at $1.04M in Q2 2023.
- 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on TFB Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.